BioCardia Presents Positive CardiAMP Cell Therapy Heart Failure Trial Two-Year Data at HFSA Annual Meeting SUNNYVALE, Calif., Oct. 03, 2022 (GLOBE NEWSWIRE) -- BioCardia®, Inc. [Nasdaq: BCDA], a developer of cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary...

Strataca Systems®, Ltd. Presents Data Demonstrating Improved Kidney Function Associated with JuxtaFlow® Renal Negative Pressure Treatment in Animal Models With and Without Congestive Heart Failure, Paving the Way For Human Clinical Trials New Data Presented as Part of Moderated Poster Session at the Heart Failure Society of America Virtual Conference held September 30 – October 3, 2020 ROSWELL, Ga., Oct. 01, 2020 (GLOBE NEWSWIRE) --...